These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma. Hattab EM; Koch MO; Eble JN; Lin H; Cheng L J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733 [TBL] [Abstract][Full Text] [Related]
3. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer? van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051 [TBL] [Abstract][Full Text] [Related]
4. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
5. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score. Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502 [TBL] [Abstract][Full Text] [Related]
6. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy. Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4. Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204 [TBL] [Abstract][Full Text] [Related]
8. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors. Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158 [TBL] [Abstract][Full Text] [Related]
9. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. Lau WK; Bergstralh EJ; Blute ML; Slezak JM; Zincke H J Urol; 2002 Jan; 167(1):117-22. PubMed ID: 11743287 [TBL] [Abstract][Full Text] [Related]
10. Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence. Sim HG; Telesca D; Culp SH; Ellis WJ; Lange PH; True LD; Lin DW J Urol; 2008 May; 179(5):1775-9. PubMed ID: 18343432 [TBL] [Abstract][Full Text] [Related]
11. A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy. Miyamoto H; Hernandez DJ; Epstein JI Hum Pathol; 2009 Dec; 40(12):1693-8. PubMed ID: 19683331 [TBL] [Abstract][Full Text] [Related]
12. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml. Makarov DV; Humphreys EB; Mangold LA; Walsh PC; Partin AW; Epstein JI; Freedland SJ J Urol; 2006 Aug; 176(2):554-8. PubMed ID: 16813888 [TBL] [Abstract][Full Text] [Related]
13. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors. Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301 [TBL] [Abstract][Full Text] [Related]
14. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients. May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719 [TBL] [Abstract][Full Text] [Related]
15. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy. Pierorazio PM; Lambert SM; Matsukhani M; Sprenkle PC; McCann TR; Katz AE; Olsson CA; Benson MC; McKiernan JM BJU Int; 2007 Nov; 100(5):1066-70. PubMed ID: 17784880 [TBL] [Abstract][Full Text] [Related]
16. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255 [TBL] [Abstract][Full Text] [Related]
17. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. Mian BM; Troncoso P; Okihara K; Bhadkamkar V; Johnston D; Reyes AO; Babaian RJ J Urol; 2002 Apr; 167(4):1675-80. PubMed ID: 11912386 [TBL] [Abstract][Full Text] [Related]
18. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. Tollefson MK; Leibovich BC; Slezak JM; Zincke H; Blute ML J Urol; 2006 Feb; 175(2):547-51. PubMed ID: 16406993 [TBL] [Abstract][Full Text] [Related]
19. Histopathological prostate cancer characteristics at radical prostatectomy after population based screening. Hoedemaeker RF; Rietbergen JB; Kranse R; Schröder FH; van der Kwast TH J Urol; 2000 Aug; 164(2):411-5. PubMed ID: 10893598 [TBL] [Abstract][Full Text] [Related]
20. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy. Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]